BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rethinking Clinical Trials - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rethinking Clinical Trials
X-ORIGINAL-URL:https://rethinkingclinicaltrials.org
X-WR-CALDESC:Events for Rethinking Clinical Trials
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180706T130000
DTEND;TZID=America/New_York:20180706T140000
DTSTAMP:20260509T062516
CREATED:20180503T184750Z
LAST-MODIFIED:20180702T170304Z
UID:10654-1530882000-1530885600@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds July 6th: No Presentation (Week of July 4th Holiday)
DESCRIPTION:Grand Rounds July 6th: No Presentation (In observance of July 4th holiday) \nWe hope to see you next week.
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-july-6th-no-presentation-week-of-july-4th-holiday/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180710T110000
DTEND;TZID=America/New_York:20180710T120000
DTSTAMP:20260509T062516
CREATED:20180706T175510Z
LAST-MODIFIED:20180706T175510Z
UID:11151-1531220400-1531224000@rethinkingclinicaltrials.org
SUMMARY:Report Release Webinar: Returning Individual Research Results to Participants
DESCRIPTION:Register now! Report release for Returning Individual Research Results to Participants \nWhen is it appropriate to return individual research results to participants? What are the risks and benefits of the practice to research participants\, the research enterprise\, and society as a whole? \nOn Tuesday\, July 10\, from 11:00 am to 12:00 pm ET\, the National Academies of Sciences\, Engineering\, and Medicine will publicly release a new report on returning individual research results to participants. The report presents a comprehensive review of the current evidence on the benefits\, harms\, and costs of returning individual research results\, while also considering the ethical\, social\, operational\, and regulatory aspects of the practice. In addition to evidence-based findings\, the report offers an approach to returning individual research results that considers the desires of the participant\, the risks and feasibility of return\, and the quality of the research laboratory. \nPresenters will include authoring committee members: \nJeffrey R. Botkin (Committee Chair)\, University of Utah School of Medicine\nAmy McGuire\, Baylor College of Medicine\nJames H. Nichols\, Vanderbilt University School of Medicine\nBray Patrick-Lake\, Duke Clinical Research Institute\nConsuelo H. Wilkins\, Vanderbilt University Medical Center and Meharry Medical College\nBrian J. Zikmund-Fisher\, University of Michigan \nRegister now! Visit http://bit.ly/ReturnofResultsRelease \nWhat: Report release for Returning Individual Research Results to Participants\nWhen: Tuesday\, July 10\, at 11:00 am ET\nHow: Register to watch the release at http://bit.ly/ReturnofResultsRelease
URL:https://rethinkingclinicaltrials.org/event/report-release-webinar-returning-individual-research-results-to-participants/
LOCATION:https://dukemed.webex.com/dukemed/j.php?MTID=m4c6e3e4827442a92338a5649cee613e6
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180711T110000
DTEND;TZID=America/New_York:20180711T120000
DTSTAMP:20260509T062516
CREATED:20180625T174629Z
LAST-MODIFIED:20180628T204418Z
UID:10970-1531306800-1531310400@rethinkingclinicaltrials.org
SUMMARY:Mind The Gap NIH Webinar Series: Stepped Wedge Cluster Randomized Designs for Disease Prevention Research
DESCRIPTION:About This Webinar \nThe stepped wedge cluster randomized design has seen a rapid increase in popularity over the past decade. It is different than the conventional parallel arm cluster randomized design in that all clusters (e.g.\, communities\, schools\, or hospitals)\, rather than half\, receive the intervention. This presentation will: \n\nExplain the unique characteristics of the stepped wedge cluster randomized design and its implications for sample size calculation and analysis.\nDiscuss the strengths and weaknesses of stepped wedge design compared to traditional designs.\n\nCan’t be there? A recording of this webinar will be available approximately one week after the session. You can view the full archive of previous Mind the Gap webinars on the NIH Office of Disease Prevention website.  \nAbout Dr. Talijaard \nDr. Monica Taljaard is a Senior Scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute (OHRI) and Associate Professor in the School of Epidemiology and Public Health at the University of Ottawa. She has a Ph.D. in Epidemiology and Biostatistics from Western University\, and her main research interests are in the design\, analysis\, and ethics of cluster randomized trials. \nDr. Taljaard will accept questions during the webinar via WebEx and Twitter. Use the hashtag #NIHMtG. \nRegistration is required \nPlease note the registration page may not work in Firefox. \nCan’t be there? A recording of this webinar will be available approximately one week after the session. You can view the full archive of previous Mind the Gap webinars on the NIH Office of Disease Prevention website. \nThis event is open to the public. Please feel free to share this information widely. \nFor more information\, please contact the Office of Disease Prevention at MindtheGap@od.nih.gov. \n 
URL:https://rethinkingclinicaltrials.org/event/mind-the-gap-nih-webinar-series-stepped-wedge-cluster-randomized-designs-for-disease-prevention-research/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180713T130000
DTEND;TZID=America/New_York:20180713T140000
DTSTAMP:20260509T062516
CREATED:20180702T165358Z
LAST-MODIFIED:20180717T180553Z
UID:11103-1531486800-1531490400@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds July 13: Clinical Trial Data Sharing: Perspectives from Participants and PCORI
DESCRIPTION:Speakers:\n\nMichelle M. Mello\, JD\, PhD\nProfessor of Law\, Stanford Law School\nProfessor of Health Research and Policy\, Stanford University School of Medicine \nSteven Goodman\, MD\, MHS\, PhD\nAssociate Dean\, Clinical and Translational Research\nProfessor of Medicine and Health Research and Policy\nStanford University School of Medicine\nVice-chair\, PCORI Methodology Committee \nTopic: Clinical Trial Data Sharing: Perspectives from Participants and PCORI\nDate: Friday\, July 13\, 2018\, 1:00-2:00 p.m. ET \n\n\nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m1a4a0665a615ae0382440edecedbdd33 \nYou must log in to the URL first.\nClick ‘Audio Conference’\nChoose ‘I will call in’\, select the Toll Free number.\nDial in using the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 739 348 059\nMeeting Password: 1234 \nFor Audio ONLY:\nCall-in toll-free number (US/Canada): 1-855-244-8681\nAccess code: 739 348 059
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-july-13-clinical-trial-data-sharing-perspectives-from-participants-and-pcori/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180720T130000
DTEND;TZID=America/New_York:20180720T140000
DTSTAMP:20260509T062516
CREATED:20180626T192635Z
LAST-MODIFIED:20180626T192635Z
UID:10981-1532091600-1532095200@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds July 20: Developing Technology-Derived Novel Endpoints for use in Clinical Trials: Recommendations and Case Examples from the Clinical Trials Transformation Initiative
DESCRIPTION:Speakers:\n\nWill Herrington\, MA\, MBBS\, MD\, MRCP\nMRC-Kidney Research UK Professor and\nDavid Kerr Clinician Scientist\nNuffield Department of Population Health\, University of Oxford \nRob DiCicco\, PharmD\nPrincipal Consultant\nTransCelerate BioPharma Inc. \nJen Goldsack\, MChem\, MA\, MBA\, OLY\nSenior Project Manager\nClinical Trials Transformation Initiative \nTopic: Developing Technology-Derived Novel Endpoints for use in Clinical Trials: Recommendations and Case Examples from the Clinical Trials Transformation Initiative\nDate: Friday\, July 20\, 2018\, 1:00-2:00 p.m. ET \n\n\nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m1a4a0665a615ae0382440edecedbdd33 \nYou must log in to the URL first.\nClick ‘Audio Conference’\nChoose ‘I will call in’\, select the Toll Free number.\nDial in using the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 739 348 059\nMeeting Password: 1234 \nFor Audio ONLY:\nCall-in toll-free number (US/Canada): 1-855-244-8681\nAccess code: 739 348 059
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-july-20-developing-technology-derived-novel-endpoints-for-use-in-clinical-trials-recommendations-and-case-examples-from-the-clinical-trials-transformation-initiative/
CATEGORIES:Grand Rounds Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180727T130000
DTEND;TZID=America/New_York:20180727T140000
DTSTAMP:20260509T062516
CREATED:20180702T170150Z
LAST-MODIFIED:20180702T170151Z
UID:11105-1532696400-1532700000@rethinkingclinicaltrials.org
SUMMARY:Grand Rounds July 27: Pilot Study for a Pragmatic Trial Comparing Chlorthalidone and Hydrochlorothiazide: Results and Lessons Learned
DESCRIPTION:Speakers:\n\nKaren Margolis\, MD\, MPH\nHealthPartners Institute\, Minneapolis\, MN \nStephen Fortmann\, MD\nKaiser Permanente Center for Health Research\, Portland\, OR \nTopic: Pilot Study for a Pragmatic Trial Comparing Chlorthalidone and Hydrochlorothiazide: Results and Lessons Learned\nDate: Friday\, July 27\, 2018\, 1:00-2:00 p.m. ET \n\n\nMeeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files\, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php. \nTo join the online meeting:\nGo to https://dukemed.webex.com/dukemed/j.php?MTID=m1a4a0665a615ae0382440edecedbdd33 \nYou must log in to the URL first.\nClick ‘Audio Conference’\nChoose ‘I will call in’\, select the Toll Free number.\nDial in using the information from the dialog box that appears.\nBe certain to use the Access Code AND the Attendee ID. \nTroubleshooting:\nIf the URL above does not work\, go to dukemed.webex.com and enter:\nMeeting Number: 739 348 059\nMeeting Password: 1234 \nFor Audio ONLY:\nCall-in toll-free number (US/Canada): 1-855-244-8681\nAccess code: 739 348 059
URL:https://rethinkingclinicaltrials.org/event/grand-rounds-july-27-pilot-study-for-a-pragmatic-trial-comparing-chlorthalidone-and-hydrochlorothiazide-results-and-lessons-learned/
CATEGORIES:Grand Rounds Event
END:VEVENT
END:VCALENDAR